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The structure of the large proteoglycan present in the bullfrog epiphy-
seal cartilage was studied by immunochemical and biochemical meth-
ods. The isolated monomer showed a polydisperse behavior on Sepha-
rose CL2B, with a peak at Kav = 0.14. Chondroitin sulfate chains were
identified by HPLC analysis of the products formed by chondroitinase
digestion and mercuric acetate treatment. These chains have approxi-
mately 38 disaccharides, a Di45:Di68 ratio of 1.6 and GalNAc4S +
GalNAc4,6S are the main non-reducing terminals. Keratan sulfate
was identified by the use of two monoclonal antibodies in Western
blots after chondroitinase ABC treatment. A keratan sulfate-rich
region (~110 kDa) was isolated by sequential treatment with chondro-
itinase ABC and proteases. We also employed antibodies in Western
blotting experiments and showed that the full length deglycosylated
core protein is about 300 kDa after SDS-PAGE. Domain-specific
antibodies revealed the presence of immunoreactive sites correspond-
ing to G1/G2 and G3 globular domains and the characterization of this
large proteoglycan as aggrecan. The results indicate the high conserva-
tion of the aggrecan domain structure in this lower vertebrate.
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Cartilage is a resilient tissue able to resist
tension and pressure forces (1). These prop-
erties are thought to result from a highly
coordinated array of various components,
amongst which are type II collagen, large
and small proteoglycans, and other non-col-
lagenous glycoproteins (2,3). The large pro-
teoglycan aggrecan consists of a core protein
to which the glycosaminoglycans (GAGs)
chondroitin sulfate (CS) and keratan sulfate
(KS) and N- and O-linked oligosaccharides
are attached (4). The GAGs have a high
negative fixed-charge density, conferring on
aggrecan its characteristic osmotic activity
(5) which, in addition to the capacity to
aggregate with hyaluronan and participate in
a concerted interplay with type II collagen
fibrils, endows the tissue with the ability to
withstand compressive forces and to distrib-
ute the load (6).
The aggrecan core protein has different
domains (Figure 1). The G1 domain at the N-
terminal consists of three subdomains and
binds to hyaluronan and link protein in huge
aggregate structures (7-9). The interglobular
domain, located between the G1 and G2
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domains, is a proteolytically sensitive region
of the molecule, centrally involved in aggre-
can catabolism (10-14). The G2 domain (15)
consists of two subdomains also present in
G1. The function of G2 is still unclear. The
two GAG substitution domains correspond
to a KS-rich region with about 50 chains
(16), and a CS-rich region with about 100
chains (17). The G3 domain consists of EGF-
like, lectin-like (18) and CRP-like motifs,
which also occur together in some cell adhe-
sion molecules (19).
We have studied the bullfrog epiphyseal
cartilage and reported that it differs from its
mammalian counterpart by lacking a colum-
nar arrangement of the chondrocytes in the
growth cartilage. Chondrocyte hypertrophy
is not associated with matrix calcification or
endochondral ossification. Moreover, there
is no secondary center of ossification (20).
This led us to believe that the identifica-
tion and characterization of the macromol-
ecules in the bullfrog epiphyseal cartilage
would be important for the understanding of
the physiology of this tissue at the cellular
and molecular levels.
Since aggrecan function is essential to
the physiology and structure of cartilage, we
used immunochemical tests to elucidate some
of the characteristics of the core protein and
biochemical assays to determine some as-
pects of the attached GAGs. Considering
that amphibians are lower vertebrates, the
results presented here demonstrate a high
conservation of the domain structure of
aggrecan.
Material and Methods
Preparation of the large proteoglycan from
the bullfrog femoral distal epiphyseal
cartilage
One-year-old bullfrogs, Rana catesbeia-
na, were purchased from a farm in Atibaia
(SP, Brazil). The femoral distal epiphyseal
cartilages were dissected out and the proteo-
glycans were extracted with 4 M guanidine-
HCl in the presence of protease inhibitors
and then dialyzed against 0.4 M guanidine-
HCl to attain associative conditions before
associative cesium chloride gradient cen-
trifugation (21). The high buoyant density
fraction (1.70 mg/ml, A1 fraction) was cen-
trifuged again under dissociative conditions
to obtain A1D1 fractions. A1D1 fractions
were sequentially dialyzed against 1 M NaCl
and water prior to subsequent analyses.
Hydrodynamic size of proteoglycan
monomers
Proteoglycans (300 µg) were dialyzed
against 0.5 M sodium acetate, pH 8.0, and
subjected to gel filtration on a Sepharose
CL2B column (0.5 x 110 cm) eluted with the
same solution at a flow rate of 0.5 ml/h.
Fractions (1 ml) were assayed for sulfated
GAG content by the dimethylmethylene blue
(DMMB) procedure (22).
Isolation of CS chains and Superose 6
chromatography
Large proteoglycans were subjected to ß-
elimination and reduction for 24 h at 45oC in
1 M sodium borohydride in 50 mM NaOH,
neutralized with acetic acid on ice, and
vacuum dried after the addition of an equal
Figure 1 - Schematic drawing of
the aggrecan core protein (A)
and the sites of reactivity of the
different antibodies employed in
the present study. G1 and G2
are 21 nm apart from each other.
Between G2 and G3 are the
keratan sulfate (KS)-rich region
and the chondroitin sulfate (CS)
substitution region. The anti-
ATEGQV antibody reacts with a
peptide present in G1. The anti-
CDAGWL antibody reacts with a
peptide sequence present in
both G1 and G2. The Lec-7 anti-
body recognizes a segment
found in the G3 domain. B is a
schematic drawing of a chon-
droitin sulfate chain attached to
a serine residue (Ser) in the core
protein. The filled circles-open
circles-open circles-open squares
sequence represents the tet-
rasaccharide xylose-galactose-
galactose-uronic acid linkage.
The filled square/open square
symbols represent the repeating
disaccharides (DDi4S, DDi6S or
DDi0S) and the dotted circle







G1 G2 KS CS G3A
B
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volume of methanol (23). The residues were
washed three times with 500 µl of methanol
to remove borate salts, dissolved in 500 µl of
4 M guanidine-HCl in 50 mM acetate buffer,
pH 6.0, and subjected to chromatography on
Superose 6 (1 x 24 cm) (Pharmacia, Uppsala,
Sweden). The column was eluted with the
same solution at a flow rate of 0.5 ml/min.
Fractions (0.5 ml) were collected and as-
sayed for sulfated GAG content by the
DMMB assay (22).
Fluorescent derivatization of chondroitinase
digestion products with 2-aminopyridine
The large proteoglycans from the A1D1
fraction (10 µg of sulfated GAGs) were di-
gested with 5 mU of chondroitinase ABC
(Seikagaku America, Falmouth, MA, USA)
in 50 µl of 100 mM ammonium acetate, pH
7.4, for 2 h at 37oC. Released products were
collected into the filtrate of prewashed
MicroCon 3 filters. Ammonium acetate was
removed in vacuo. The residue was dis-
solved in 500 µl of water and redried. Diges-
tion products were derivatized with 2-
aminopyridine (AP) (23). AP was freshly
prepared before use by adding 500 mg to 100
µl of glacial acetic acid, which had been
heated to and maintained at 65oC, with re-
peated vortexing until it was completely dis-
solved. This reagent (20 µl) was added to 20-
100 nmol of the chondroitinase digestion
products. After incubation of the mixture for
24 h at 37oC, 5 µl of 6 M borane dimethyl-
amine in glacial acetic acid was added and
allowed to stand overnight at 37oC. Acid was
removed by speed-vac evaporation and
samples were stored at -20oC until the time
for analysis. Mono- and disaccharide stan-
dards were also subjected to the chondroiti-
nase digestion procedure before fluorescent
derivatization. AP-derivatized unsaturated
disaccharides were decomposed by treat-
ment with 120 µl of 35 mM mercuric acetate,
pH 5.0. Mercuric ions were removed in vacuo
before chromatography.
HPLC separation of AP-derivatized
chondroitinase digestion products
AP derivatives (23) were dissolved in
100 µl of water and passed over a 100 µl bed
volume of Dowex H+ (BioRad Laboratories,
Richmond, CA, USA) immediately before
loading onto an AS4A Ion Pac column equili-
brated with 1 mM sodium trifluoroacetate,
pH 7.0, in a Dionex AI-450 HPLC system.
Samples were eluted at a flow rate of 1 ml/
min with a step gradient of trifluoroacetate
(10 mM, 6 min; 10-50 mM, 4 min; 50-150
mM, 17 min; 150-250 mM, 13 min; 250-500
mM, 10 min). The eluant was monitored by
fluorescent detection with an excitation wave-
length of 310 nm and emission wavelength
of 410 nm, using an in-line fluorimeter
(Shimadzu Corporation, Tokyo, Japan).
Identification of KS and characterization of
the KS-rich region
The large proteoglycans (1.0 mg of sul-
fated GAGs) were loaded onto a Sepharose
CL6B column (Pharmacia) (0.6 x 120 cm)
and eluted with 4 M guanidine-HCl in 50
mM sodium acetate, pH 6.0, at a flow rate of
5 ml/h. The peak eluted in the void volume
of the column was digested with chondroiti-
nase ABC (Seikagaku America) (24) (10
mU/mg of sulfated GAG), subjected to SDS-
PAGE on a 3-16% gradient gel (25) and
assayed by Western blotting with the mono-
clonal antibodies MST1 (produced by im-
munization with the large proteoglycan from
the hammerhead shark cartilage; non-diluted
culture medium) (26) and 4-A-4 (1:1000)
(27) against KS, as described below. An-
other gel was run under the same conditions
and stained with 0.25% Alcian blue in 3%
acetic acid. For the isolation of the KS-rich
region, the large proteoglycan (7.5 mg of
sulfated GAG) was digested with chondroi-
tinase ABC (10 mU/mg) in 0.1 M Tris-ace-
tate buffer, pH 7.3, for 18 h at 37oC. The
chondroitinase-treated product was subse-
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quently digested with trypsin and then with
chymotrypsin (Sigma Chemical Co., St.
Louis, MO, USA) at concentrations of 2 µg
enzyme/mg of the initial sulfated GAG, for
10 h at 37oC in the same buffer. The material
was then chromatographed on a Sepharose
CL6B column (0.6 x 120 cm) in 0.5 M
sodium acetate, pH 7.0, and eluted at a flow
rate of 5 ml/h as previously described by
Heinegård and Axelsson (28). A peak con-
taining material that showed metachromasy
with DMMB and was devoid of uronic acid
(as detected by the orcinol reaction) (29) was
found. Fractions of this peak were pooled
and electrophoresed on 3-16% gradient SDS-
PAGE for 3 h at 25 mA, with or without prior
digestion with keratanase (Seikagaku Ame-
rica). The gel was stained with Alcian blue
as described above.
Deglycosylation, SDS-PAGE and Western
blotting of the core protein
A1D1 fractions were deglycosylated by
sequential treatment with chondroitinase
ABC (proteinase free; Seikagaku America),
keratanase II (Seikagaku America; 0.7 mU/
100 µg of sulfated GAG) and endo-ß-gly-
cosidase (Seikagaku America; 0.7 mU/100
µg of sulfated GAG). Thirty micrograms of
the initial sulfated GAGs were subjected to
SDS-PAGE on precast 4-12% gels (Novex,
San Diego, CA, USA) for 90 min at 125 V
(24). The material was electrotransferred onto
nitrocellulose using an XCELL transfer unit
(Novex) (30). Membranes were blocked with
5% (w/v) skim milk powder in Tris-buffered
saline (0.5 M NaCl and 20 mM Tris, pH 7.5),
containing 0.1% Tween 20 (TST), for 1 h at
room temperature. The polyclonal antibod-
ies used were anti-ATEGQV (1:5000) (which
reacts with the IgG loop of the G1 domain of
the aggrecan; Kenagy A, Wight T and Sandy
JD, unpublished results), anti-CDAGWL
(1:3000) (which detects the protein tandem
repeat loops of the G1 domain, obtained
from Dr. Steve S. Carlson, University of
Washington, Seattle, WA, USA) and Lec-7
(raised against a peptide contained in the
lectin-like motif of the G3 domain, obtained
from Dr. Kurt Doege, Shriners Hospital for
Children, Portland, OR, USA) (1:5000) poly-
clonal antibodies (Figure 1). The anti-chon-
droitin 4-sulfate (C4S) stub (2B6 clone,
1:750) (31) and anti-chondroitin 6-sulfate
(C6S) stub (3B3 clone, 1:5000) (32) mono-
clonal antibodies and the peroxidase-conju-
gated secondary antibody (1:5000) were all
diluted in 1% (w/v) milk powder in TST.
Immunoreactivity was developed using the
ECL detection kit (Amersham Corporation,
Arlington Heights, IL, USA) and exposure
to Hyperfilm (Amersham). Rat chondrosar-
coma aggrecan (13) was included for com-
parison.
Results
The hydrodynamic size of the proteoglycan
monomer and of the CS chains
Figure 2 shows the chromatographs ob-
tained for the proteoglycan monomers
extracted from the bullfrog epiphyseal carti-
lage by gel filtration on Sepharose CL2B.
Kav was 0.14 and Kav range (50% of the
peak) was 0 to 0.34. Glycosaminoglycan
chains released by ß-elimination of the pro-
teoglycans present in the A1D1 fraction were




-0.4 -0.2 0.0 0.2 0.4 0.6 0.8 1.0
Kav
Figure 2 - Hydrodynamic size of
large proteoglycan monomers.
Gel filtration of proteoglycan
monomers present in A1D1 frac-
tions of the ultracentrifugation.
The material present in A1D1
fractions was dialyzed against
0.5 M sodium acetate, pH 8.0,
and loaded onto a Sepharose
CL2B column (0.6 x 120 cm).
Fractions (0.5 ml) were assayed
for the amount of glycosami-
noglycans by the DMMB proce-
dure.
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chains eluted as a single peak with Kav =
0.40 (Figure 3).
Fluorescent HPLC analysis of chondroitinase
ABC digests
AP-derivatized chondroitinase digestion
products were submitted to ion-exchange
HPLC analysis with measurement of all in-
ternal disaccharides and non-reducing ter-
minals (33). Most of the fluorescent prod-
ucts present in the digests were sulfated
Ddisaccharides (DDi, unsaturated disaccha-
ride) (97.4%) (Figure 4A and Table 1). The
DDi4S:DDi6S ratio was 1.6. GalNAc4S,
GalNAc4,6S and the saturated disaccharides
GlcA-GalNAc4S (Di4S) and Glc-GalNAc6S
(Di6S) were identified as the non-reducing
termini of the CS chains (Figure 4) and
corresponded to 2.6% of the total chondroi-
tinase digestion products. The average num-
ber of repeating disaccharides per chain was
estimated by the ratio of interior DDi to non-
reducing termini (Table 1). The analyses
also showed that sulfated GalNAc residues
were the most abundant termini in the bull-
frog CS chain, representing 96% of the total
non-reducing termini (Figure 4B and Table 1)
Figure 3 - Hydrodynamic size of
large proteoglycan chondroitin
sulfate. A 250-µg aliquot of large
proteoglycans was treated with
sodium borohydrate and NaOH
to release the composing gly-
cosaminoglycan (GAG) chains.
The released GAGs were chro-
matographed on Superose 6
and fractions were assayed for
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Figure 4 - AS4A ion chromatography-derivatized products from a chondroitinase-digested large proteoglycan. A and
B, The samples were digested with chondroitinase ABC and derivatized, and portions (200 ng) were
chromatographed by AS4A HPLC. Column effluents were monitored for fluorescence (B). Other portions of
derivatized products were treated with mercuric acetate prior to HPLC fractionation and monitoring. 2-
Aminopyridine-derivatized (AP) products were identified by comparison of their elution times relative to standards
(1, GalNAc4S-AP; 2, GalNAc4,6S-AP; 3, DDi4S-AP; 4, DDi6S-AP; 5, Di4S-AP; Di6S-AP).
Table 1 - Quantitative data on chondroitin sulfate (CS) chain internal and non-reducing terminal disaccharide
composition.
aData are reported as the total area under the corresponding peaks and the percent of the total chondroitinase
digestion products. bData are reported as the number of disaccharides calculated from the ratio between the
amount of internal Ddisaccharides (DDi) and the amount of non-reducing terminals.
DDi4S/DDi6S Total Non-reducing terminals CS chain
terminalsa sizeb
GalNAc4S GalNAc4,6S Di4S Di6S
1.6 0.49 (2.6%) 0.29 (59%) 0.18 (37%) 0.01 (2%) 0.01 (2%) ~38
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in the form of GalNAc4S and GalNAc4,6S,
which corresponded to 59 and 37%, respec-
tively. Both Di4S and Di6S termini were
present in equal amounts (2% each of the
total) (Figure 4B and Table 1), and hence 4%
of the CS chains terminated as GlcA.
Identification of KS and characterization of
the KS-rich region
The initial guanidine-HCl extract was
chromatographed on Sepharose CL6B (Fig-
ure 5A). The peak eluted at the void volume
was treated with chondroitinase ABC. The
digestion products were electrophoresed by
SDS-PAGE. Components with high relative
molecular mass were developed after stain-
ing with Alcian blue. The non-digested pro-
teoglycan was in the stacking gel and the
chondroitinase ABC-treated proteoglycan
migrated as a high molecular mass compo-
nent at the top of the separating gel (Figure
5B). Other samples were electroblotted onto
nitrocellulose membranes and incubated with
the monoclonal antibody MST1 (Figure 5C)
or 4-A-4 (Figure 4D). Immunoreactivity for
both MST1 and 4-A-4 was found in high
molecular mass components only after chon-
droitinase digestion. Non-digested proteo-
glycans did not react with either monoclonal
antibody. To isolate the KS-rich region, the
monomers of A1D1 were digested first with
chondroitinase ABC and then with a trypsin/
chymotrypsin combination. The digestion
products were chromatographed on a Sepha-
rose CL6B column (Figure 6A). The peak
detected by metachromasy with DMMB was
devoid of uronic acid, as detected by the
orcinol reaction. This product migrated as a
polydisperse band centered at 110 kDa in a
3-16% gradient SDS-PAGE, after Alcian blue
staining (Figure 6B). This Alcian blue-posi-
































Figure 5 - Identification of keratan sulfate in large proteoglycans. A, Chromatography on Sepharose CL6B of large proteoglycan total
extracts. PI, Peak eluted in the void volume. B, SDS-PAGE plus Alcian blue staining of the large proteoglycans present in PI. The large
proteoglycan found in the stacking gel was digested by chondroitinase ABC and was retained at the top of the separating gel. C and D,
Immunochemical identification of keratan sulfate in large proteoglycans using the MST1 and 4-A-4 monoclonal antibodies, respectively. Vo,
Void volume; Vt, total volume.
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Identification of G1/G2, G3, C4S stubs and
C6S stubs in a large proteoglycan
The reactivity of the large proteoglycan
core protein to anti-ATEGQV, anti-CDAGWL,
anti-Lec-7, anti-C4S stubs (2B6) and anti-C6S
stubs (3B3) was examined by Western blot
analysis. The anti-ATEGQV antibody reacted
with a single band at about 300 kDa in the
A1D1 fraction (Figure 7A, lane 4) and with
fast moving species in A1 fractions (Figure
7A, lane 3). The anti-CDAGWL detected at
least five species with molecular mass be-
tween 130 and 300 kDa in the A1 fractions
(Figure 7B, lane 3). The A1D1 fraction pre-
sented the same molecular species in different
amounts and a further 250-kDa band, besides
the 300-kDa full core protein. A variety of
molecular species reactive to the Lec-7 anti-
body was found in the A1 fraction. The 300-
kDa component showed strong immunoreac-
tivity to this antibody (Figure 7C, lanes 3 and
4). Immunoreactivity to the 3B3 and 2B6 mono-
clonal antibodies was shown for many bands
in the A1 and A1D1 fractions obtained by
ultracentrifugation. Three main species of 60,
75 and 100 kDa were found in the A1 fraction
(lane 3 in Figure 7D and E). Other bands in the
A1 and A1D1 fractions migrated between 130
and 250 kDa (Figure 7D and E, lanes 3 and 4).
The 300-kDa band also showed reactivity to
these two antibodies.
Discussion
The bullfrog epiphyseal cartilage shows
a unique morphology and has a distinctive
role in long bone growth, as compared to the
mammalian and avian models (19). We used
immunochemical and biochemical assays for
the identification of structural and composi-
tional characteristics of the large proteogly-
can found in the bullfrog epiphyseal carti-
lage, as compared to the classical model for
aggrecan.
Chondroitin sulfate chains were isolated
and shown to be about 38 disaccharides long
and to have DDi4S as the predominant form
of sulfation (DDi4S:DDi6S = 1.6). Consider-
ing the number of internal disaccharides, the
tetrasaccharide linkage and 300 Da as the
mean molecular mass for the non-reducing
terminal (23,34), it appears that the CS chains
in the young adult bullfrog epiphyseal carti-

















































0.7 Figure 6 - Characterization of the
keratan sulfate (KS)-rich region
in large proteoglycans. A, Seph-
arose CL6B of the products ob-
tained by sequential treatment
with chondroitinase ABC, tryp-
sin and chymotrypsin. A KS-rich
region was identified by the
presence of sulfated glycosami-
noglycan (DMMB reaction -
A525 - circles) and the lack of
reaction for uronic acid (orcinol
reaction - A670 - squares). B,
SDS-PAGE of the material pre-
sent in the peak corresponding
to the KS-rich region prior to and
after keratanase digestion. Kera-
tanase treatment eliminates the
polydisperse band with a mo-
lecular mass centered at 110
kDa. Alcian blue staining. Vo,
Void volume; Vt, total volume.
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Since DDi0S was not detected by the
HPLC procedure employed in the present
study, it is possible that these chains are
longer. However, the presence of nonsulfated
disaccharides needs to be confirmed by
complementary methodology.
These structural characteristics of the CS
chains correspond to those found in young
human aggrecan, with respect to the chain
length, and to the aged human aggrecan,
with respect to the structure of the non-
reducing terminal, considering the presence
of GalNAc4,6S, which is only found in older
individuals (33). It is worth mentioning that
GalNAc4S is the only form of GalNAc at the
non-reducing terminal of CS in the newborn
Figure 7 - Western blot of A1
and A1D1 proteoglycans with
the anti-ATEGQV (A), anti-
CDAGWL (B), Lec-7 (C), 3B3 (D)
and 2B6 (E) antibodies. A1 (lanes
3) and A1D1 (lanes 4) extracts
were deglycosylated, electro-
phoresed on 4-12% gradient
gels and blotted onto nitrocellu-
lose for the reaction with the dif-
ferent antibodies. Lanes 1, Mo-
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and young human aggrecan (33).
Keratan sulfate was also identified as a
component of the bullfrog large proteogly-
can using two monoclonal antibodies (4-A-4
and MST1 clones) on Western blots. Anti-
body reactivity is hindered by the presence
of the CS chains, as indicated by the fact that
the reaction with either antibody is only
achieved after chondroitinase treatment. The
isolation of a KS-rich region suggests further
similarity with the mammalian aggrecan. We
have shown by SDS-PAGE that the KS-rich
region is about 110 kDa. This is really close
to the 122 kDa determined for the KS-rich
region of the bovine aggrecan (28). Though
it is well known that KS concentrates in a
KS-rich region after the G2 domain and
before the CS substitution region in all
aggrecan molecules already described, ex-
cept for the rat chondrosarcoma aggrecan,
which lacks this KS-rich region (35,36), its
exact location in the bullfrog molecule still
needs to be determined.
The use of different antibodies has re-
vealed important aspects of the large proteo-
glycan structure. The 2B6 and 3B3 antibod-
ies, besides showing the existence of C4S
and C6S stubs in the core protein after chon-
droitinase digestion, also revealed that the
deglycosylated full core protein is about 300
kDa. On the other hand, the positive reac-
tions to the anti-ATEGQV and Lec-7 anti-
bodies are strong evidence for the existence
of G1 and G3 domains. Though CDAGWL
is a sequence found in G2, it is also present
in G1 and, as such, cannot be used as an
indicator of the existence of this globular
domain. However, transmission electron
microscopy of rotary shadowed isolated
molecules has demonstrated morphologically
the existence of the G2 domain besides G1
and G3 (Covizi DZ, Keene DR, Plaas AHK,
Sandy JD and Carvalho HF, unpublished
results).
The presence of molecular species with
molecular mass below 300 kDa may repre-
sent degradation products containing the
globular domains (11-14). Whether they rep-
resent normal catabolic products of the ag-
grecan remains to be ascertained. Since pro-
tease inhibitors were added to the extracting
buffer, we do not consider the possibility of
artifactual degradation of the proteoglycan
monomer during extraction.
The characteristics of the large proteo-
glycan of the bullfrog epiphyseal cartilage
described in this paper permit us to suggest
that it is aggrecan. Furthermore, they also
reveal a high conservation of its domain
structure and glycosaminoglycan substitu-
tion and that the unique characteristics of the
bullfrog epiphyseal cartilage are not attribut-
able to differences in its aggrecan structure.
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